Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Ross

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Transplantation|July 9, 2005
Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipientsChristopher F Bryan, Franz T Winklhofer, Daniel Murillo, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2025
High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinomaRebecca E Parker, Leon McSwain, Wei Zhou, et al.
3 Biotech|August 28, 2025
Protective efficacy of emodin in Swiss Albino mice induced with Dalton Ascitic lymphomaJesse Joel, Harish Babu Kolla, Sai Rupini Vemuri, et al.
Molecular Cancer Therapeutics|December 9, 2020
Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer MetastasisRui Jin, Boxuan Liu, Xiuju Liu, et al.
Communications Biology|January 30, 2021
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivoBriana Rackley, Chang-Soo Seong, Evan Kiely, et al.
Cancer Reports (Hoboken, N.J.)|October 17, 2022
Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient-derived xenograftsRegina Rab, Annette Ehrhardt, Bhagelu R Achyut, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2020
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumorsWilliam B Parker, Paula W Allan, William R Waud, et al.
Journal of the National Cancer Institute|June 13, 2025
Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from femalesYijian Fan, Rui Jin, Lenore Monterroza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective InvasionAlessandra M Richardson, Lauren S Havel, Allyson E Koyen, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Transplantation|July 9, 2005
Improving access to kidney transplantation without decreasing graft survival: long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipientsChristopher F Bryan, Franz T Winklhofer, Daniel Murillo, et al.
Journal of Cancer Research and Clinical Oncology|July 27, 2025
High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinomaRebecca E Parker, Leon McSwain, Wei Zhou, et al.
3 Biotech|August 28, 2025
Protective efficacy of emodin in Swiss Albino mice induced with Dalton Ascitic lymphomaJesse Joel, Harish Babu Kolla, Sai Rupini Vemuri, et al.
Molecular Cancer Therapeutics|December 9, 2020
Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer MetastasisRui Jin, Boxuan Liu, Xiuju Liu, et al.
Communications Biology|January 30, 2021
The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivoBriana Rackley, Chang-Soo Seong, Evan Kiely, et al.
Cancer Reports (Hoboken, N.J.)|October 17, 2022
Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient-derived xenograftsRegina Rab, Annette Ehrhardt, Bhagelu R Achyut, et al.
Cancer Chemotherapy and Pharmacology|January 10, 2020
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumorsWilliam B Parker, Paula W Allan, William R Waud, et al.
Journal of the National Cancer Institute|June 13, 2025
Suppression of LKB1-mutant lung adenocarcinoma by natural killer cells from femalesYijian Fan, Rui Jin, Lenore Monterroza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2017
Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective InvasionAlessandra M Richardson, Lauren S Havel, Allyson E Koyen, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancerJunghui Koo, Chang-Soo Seong, Rebecca E Parker, et al.
Pageof 4